National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 183 cases where Location is U.S., Territories, or Unknown and Vaccine is COVID19 and Manufacturer is JANSSEN and Symptom is Guillain-Barre syndrome



Case Details

This is page 5 out of 19

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14   next


VAERS ID: 1291625 (history)  
Form: Version 2.0  
Age: 56.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-03-23
Onset:2021-03-23
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-05-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805031 / UNK - / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: - Albuterol HFA - Calcium citrate vitamin D3 - Cyclosporine - Epipen 2-pak - Allegra - Flucelvax quad 2020-2021 - Glucosamine/chondrotin sulfate - Hydocholathiazide - Losartan - Mometasone formoterol - Montelukast - MVI adult 1 with Vita
Current Illness:
Preexisting Conditions: - Essential hypertension - Moderate persistent asthma - Obesity - Thyroid nodule
Allergies: - Pollen - Prednisone- frequent urination
Diagnostic Lab Data:
CDC Split Type:

Write-up: GBS/AIDP


VAERS ID: 1297020 (history)  
Form: Version 2.0  
Age: 60.0  
Sex: Male  
Location: New Jersey  
Vaccinated:2021-04-04
Onset:2021-04-04
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-05-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN RX#705539-00 / 1 RA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Abdominal pain upper, Aphasia, Blindness, Gait inability, Guillain-Barre syndrome, Muscular weakness, Pain
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Dementia (broad), Dystonia (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Glaucoma (broad), Optic nerve disorders (broad), Demyelination (narrow), Retinal disorders (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: no
Current Illness: None
Preexisting Conditions: None
Allergies: no
Diagnostic Lab Data:
CDC Split Type:

Write-up: In the beginning a very strong pain arms whole body after the stomach started the back and everything got worse for 4 days going to and from the emergency room and then still hospitalized all due to problems after the vaccine in the last exam the variant was positive for guillen barrer before discovering this he lost his sight for two hours he cannot walk he lost the strength of his limbs and his pressure shot up he has dysphacia and is still hospitalized with physical therapy


VAERS ID: 1303022 (history)  
Form: Version 2.0  
Age: 66.0  
Sex: Male  
Location: Florida  
Vaccinated:2021-03-13
Onset:2021-03-25
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-05-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Angiogram cerebral normal, CSF protein increased, CSF test abnormal, Computerised tomogram head normal, Guillain-Barre syndrome, Magnetic resonance imaging head normal, Muscular weakness, Paraesthesia
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 9 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Eliquis, Amlodipine, Benazepril, Metformin, Oxybutynin, Gemfibrozil, Sildenafil
Current Illness: None
Preexisting Conditions: hypertension, non insulin-dependent diabetes mellitus, dyslipidemia, prostate cancer s/p prostatectomy, history of deep vein thrombosis and pulmonary embolism
Allergies: No known drug allergies
Diagnostic Lab Data: 3/28 - CSF with albuminocytologic dissociation, noncontrast head CT and MRI/MRA brain without acute findings
CDC Split Type:

Write-up: Bilateral lower extremity weakness, bilateral hand paresthesia, areflexia - diagnosed as Guillain Barre Syndrome by neurology team


VAERS ID: 1306308 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:2021-04-04
Submitted: 0000-00-00
Entered: 2021-05-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210510750

Write-up: POSSIBLE GUILLAIN-BARRE SYNDROME; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient''s weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 23-MAR-2021 for prophylactic vaccination. The patient''s vaccine Anatomical Approach site was not reported. The batch number was not reported and has been requested. No concomitant medications were reported. On Easter (04-APR-2021), 12 days after vaccine administration, the patient started having symptoms which led to the patient being tentatively diagnosed with Guillain-Barre syndrome. No further details provided. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of possible Guillain-Barre syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender''s Comments: V0: 20210510750-covid-19 vaccine ad26.cov2.s-possible Guillain-Barre syndrome. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).


VAERS ID: 1307244 (history)  
Form: Version 2.0  
Age: 27.0  
Sex: Male  
Location: North Carolina  
Vaccinated:2021-04-09
Onset:2021-04-29
   Days after vaccination:20
Submitted: 0000-00-00
Entered: 2021-05-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 UN / IM

Administered by: Private       Purchased by: ?
Symptoms: CSF protein increased, Facial paralysis, Guillain-Barre syndrome, Hypoaesthesia, Paraesthesia
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Demyelination (narrow), Hearing impairment (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: Erythromycin, Sulfa
Diagnostic Lab Data: CSF protein prominently elevated at 94. Findings consistent with variant Guillain Barre syndrome
CDC Split Type:

Write-up: Patient admitted to the hospital on 5/10/2021 with bilateral facial nerve palsies, followed by numbness and tingling of both arms and legs. Symptoms starting to resolve.


VAERS ID: 1308069 (history)  
Form: Version 2.0  
Age: 37.0  
Sex: Female  
Location: Wisconsin  
Vaccinated:2021-04-09
Onset:2021-04-27
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-05-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 LA / SYR

Administered by: Public       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Lumbar puncture
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Ompemrozal, allegra
Current Illness: NA
Preexisting Conditions: NA
Allergies: Sulfa
Diagnostic Lab Data: Lumbar puncture
CDC Split Type:

Write-up: Developed Guillian Barre


VAERS ID: 1309969 (history)  
Form: Version 2.0  
Age: 61.0  
Sex: Female  
Location: Michigan  
Vaccinated:2021-03-13
Onset:2021-04-09
   Days after vaccination:27
Submitted: 0000-00-00
Entered: 2021-05-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805025 / 1 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Back pain, Computerised tomogram head, Guillain-Barre syndrome, Immunoglobulin therapy, Lumbar puncture abnormal, Magnetic resonance imaging spinal abnormal, Magnetic resonance imaging thoracic, Muscular weakness, Subacute inflammatory demyelinating polyneuropathy
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Retroperitoneal fibrosis (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Multivitamin daily
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: Spinal tap, lumbar MRI, Thoracic MRI, Brain CT Scan, numerous neurological clinical exams, other?
CDC Split Type:

Write-up: Acute Inflammatory Demyelinating Polyneuropathy/Guillain-Barre Syndrome, 6-day in-patient hospital admission, IVIG for 5 days, outcome undetermined as yet. Initial symptoms include severe low back pain for a week followed by bilateral leg weakness and ascending paralysis.


VAERS ID: 1314915 (history)  
Form: Version 2.0  
Age: 42.0  
Sex: Female  
Location: Alaska  
Vaccinated:2021-04-10
Onset:2021-04-24
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-05-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 19 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Guillian Barre syndrome, Bilateral LE weakness


VAERS ID: 1315729 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: New Jersey  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-05-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 30 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Guillain Barre syndrome
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210518047

Write-up: GUILLAIN BARRE REACTIVATED; This spontaneous report received from a consumer via a company representative (Social media) concerned a male of unspecified age. The patient''s height, and weight were not reported. The patient''s concurrent conditions included Guillain-Barre. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, 1 total dose was administered on 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced Guillain-Barre reactivation and was hospitalized for a month. It was reported that "Guillain-Barre has woke him up with the vaccine". The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of Guillain-Barre reactivated was not reported. This report was serious (Hospitalization Caused / Prolonged.; Sender''s Comments: V0.20210518047-COVID-19 Vaccine Ad26.COV2.S -Guillain-Barre reactivated. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY


VAERS ID: 1316012 (history)  
Form: Version 2.0  
Age: 60.0  
Sex: Male  
Location: Minnesota  
Vaccinated:2021-04-29
Onset:2021-05-12
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-05-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 204A21A / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Abdominal pain, Back pain, Guillain-Barre syndrome, Magnetic resonance imaging, Paraesthesia
SMQs:, Acute pancreatitis (broad), Peripheral neuropathy (narrow), Retroperitoneal fibrosis (broad), Guillain-Barre syndrome (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Lipitor
Current Illness: None
Preexisting Conditions: Left knee pain
Allergies: None
Diagnostic Lab Data: 5/13/21 MRI
CDC Split Type:

Write-up: Patient developed paresthesia/sensory changes and lower back and abdominal pain. Found to have likely Guillain Barre syndrome. No motor involvement and discharged home.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=5&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19&VAXMAN=JANSSEN&STATE=NOTFR

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166